Similar articles

• Incidence of resistance to primary and secondary antituberculosis drugs in isolates of M. tuberculosis from cases of pulmonary tuberculosis.

  Kothadia SN, Sengupta SR. Kothadia SN, et al. Indian J Chest Dis Allied Sci. 1984 Jul-Sep;26(3):163-6. Indian J Chest Dis Allied Sci. 1984. PMID: 6443608 No abstract available.
• [Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli].

  Janowiec M, Zwolska-Kwiek Z, Wiśniewska A, Wróblewska H. Janowiec M, et al. Pneumonol Pol. 1977 Jun;45(6):425-30. Pneumonol Pol. 1977. PMID: 406600 Polish. No abstract available.
• Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10.

  Lai CC, Tan CK, Huang YT, Liao CH, Hsueh PR. Lai CC, et al. J Antimicrob Chemother. 2011 Oct;66(10):2437-8. doi: 10.1093/jac/dkr302. Epub 2011 Jul 27. J Antimicrob Chemother. 2011. PMID: 21798881 No abstract available.
• [Molecular mechanisms of drug resistance of Mycobacterium tuberculosis].

  Stepanshin IuG, Stepanshina VN, Shemiakin IG. Stepanshin IuG, et al. Antibiot Khimioter. 1999;44(4):39-43. Antibiot Khimioter. 1999. PMID: 10483496 Review. Russian. No abstract available.
• Mode of action of antituberculous drugs and mechanisms of drug resistance in Mycobacterium tuberculosis.

  Rastogi N, David HL. Rastogi N, et al. Res Microbiol. 1993 Feb;144(2):133-43. doi: 10.1016/0923-2508(93)90028-z. Res Microbiol. 1993. PMID: 8337471 Review. No abstract available.